Composition for prevention and treatment of inflammation or improving immune regulation

A combination of cellulose, xyloglucan, and pectin addresses the challenge of inflammatory conditions during the weaning period by reducing pro-inflammatory cytokines and enhancing anti-inflammatory responses, thereby improving immune regulation in young individuals.

WO2025237886A1PCT designated stage Publication Date: 2025-11-20SOCIETE DES PRODUITS NESTLE SA
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
PCT/EP2025/062873
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-05-14
Filing Date
2025-05-12
Publication Date
2025-11-20

Smart Images

  • Figure IMGF000016_0001
    Figure IMGF000016_0001
  • Figure IMGF000017_0001
    Figure IMGF000017_0001
  • Figure IMGF000017_0002
    Figure IMGF000017_0002
Patent Text Reader

Abstract

The present invention relates to a combination comprising cellulose, xyloglucan and pectin in effective amount for use in preventing or treating an inflammatory condition and / or disease in a young individual, preferably in infant during weaning period. The present invention further relates to compositions and methods for preventing or treating an inflammatory condition and / or disease in a young individual, preferably in an infant during weaning period.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • External medicine for treating dermatitis

    US7897161B2

  • Compositions and methods using a combination of at least one fiber and at least one probiotic to improve microbiome resilience

    WO2022268759A1

  • method

    WO2023281037A1